Health on MSN4 天
What To Know About HR+/HER2- Breast Cancer
HR+/HER2- breast cancer involves cells that test positive for hormone receptors and negative for HER2 proteins. It's the most ...
pharmaphorum1 天
EU starts review of Enhertu in HER2-ultra-low breast cancer
The EMA has started a review of AstraZeneca and Daiichi Sankyo's antibody-drug conjugate (ADC) that could see the drug being used in advanced breast cancer ... positive and either HER2-low or ...
pharmaphorum6 天
Roche gets FDA approval for HER2 breast cancer diagnostic
The FDA has approved Swiss pharmaceutical company Roche’s first companion diagnostic for identifying those patients with HER2 low-metastatic breast cancer who are eligible for ENHERTU.
Stockhead on MSN6 天
Bargain Barrel: Four ASX cancer-fighting stocks with market caps under $35 million
Several ASX-listed healthcare companies with low market caps are making strides in tackling cancer,  a leading cause of death ...
oncnursingnews3 天
Robert’s Journey With HER2-Positive Upper GI Cancer
Experts discuss Robert’s journey with HER2-positive upper gastrointestinal (GI) cancer, highlighting key treatment approaches and challenges. Now Viewing EP: 1 .
Columbus Dispatch6 天
Central Ohio woman's cancer diagnosis drives her to educate on Black health disparities
(This story has been updated to correct the month in 2023 when an ultrasound found breast cancer.) Shanise Pearce says the scary words out loud. Cancer. Breast cancer. Chemotherapy. Mastectomy.
Sky6 天
Breast cancer cases and deaths set to surge, study suggests
The number of women diagnosed with breast cancer and who die from the disease is set to rise significantly over the next three decades. In the UK, breast cancer cases are projected to rise by 21% ...